ArticleAmerican journal of translational research2025
Gasless endoscopic thyroidectomy for papillary thyroid microcarcinoma: safety and feasibility.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the comparative effectiveness of gasless endoscopic thyroidectomy (GET) versus conventional open thyroidectomy (COT) in the management of papillary thyroid microcarcinoma (PTMC).
methodsA retrospective study of 150 PTMC cases was conducted, comparing patients treated with COT (COT group, n=70) to those undergoing GET (GET group, n=80). Key outcomes, including operating time (OT), hospital length of stay (HLOS), intraoperative blood loss (IBL), postoperative drainage volume, central lymph node dissection count, efficacy, postoperative complications, pain intensity, thyroid hormone levels, inflammatory cytokines, and cosmetic satisfaction, were compared between the groups.
resultsThe GET group demonstrated significantly longer OT and greater postoperative drainage, therapeutic efficacy, and aesthetic satisfaction compared to the COT group(all P<0.05). However, the GET group showed lower IBL, pain intensity, and complication rates (all P<0.05). Additionally, variations in thyroid hormones and inflammatory cytokines were less pronounced in the GET group (all P<0.05). There were no significant differences in HLOS or the number of central neck lymph nodes dissected between the two groups (both P<0.05).
conclusionGET surgery is a safe and feasible option for PTMC. It offers advantages such as better thyroid function preservation, reduced invasiveness and physiological stress, superior cosmetic outcomes, and less postoperative pain, supporting its clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.